2,117
Participants
Start Date
September 6, 2011
Primary Completion Date
January 30, 2015
Study Completion Date
January 30, 2015
Data collection
Socio-demographic information, medical history, yellow fever vaccination history and dengue suspicion data collection.
Blood sample collection
A blood sample will be collected at each of the three scheduled study visits and any time during the study that dengue is suspected. Samples collected at scheduled visits will be tested for anti-dengue antibodies. Samples collected at visits for dengue suspicion will be tested for dengue diagnosis.
GSK Investigational Site, Fortaleza
Lead Sponsor
GlaxoSmithKline
INDUSTRY